NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) – Global Forecast to 2030

NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) – Global Forecast to 2030

NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic)—Global Forecast to 2030

The global NGS library preparation market is projected to reach $3.62 billion by 2030, at a CAGR of 14.8% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the declining costs of sequencing, the increasing prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, and rising R&D investments and healthcare expenditures.

Furthermore, increasing applications of next-generation sequencing technology and collaborations between vendors to develop automated library preparation protocols provide a significant growth opportunity for this market. However, the availability of alternative technologies and the low chances of identifying positive actionable mutations for precision medicine may restrain the growth of this market. Additionally, the regulatory and standardization concerns in diagnostic testing and the limited expertise and sequencing capabilities of small & mid-sized laboratories pose a major challenge for the players operating in this market.

Based on product, in 2023, the reagents & consumables segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased demand for reagents & consumables for NGS library preparation due to the high penetration of NGS technologies in disease diagnostics and genomic research.

Based on application, in 2023, the disease diagnostics segment is expected to account for the largest share of the NGS library preparation market. The increased utilization of NGS technologies, especially in precision medicine and companion diagnostics, and growing adoption in infectious disease diagnostics is expected to boost the growth of this segment.

Based on sequencing type, in 2023, the targeted sequencing segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased adoption of this sequencing type due to its advantages, such as cost-effectiveness and rapid sequencing for identifying specific gene-associated diseases.

Based on end user, in 2023, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased hospitalization rates, especially in developing economies, increased penetration of NGS technologies in hospitals & diagnostic laboratories, and the high prevalence of various infectious & chronic diseases requiring complex genomic sequencing.

An in-depth analysis of the geographical scenario of the global NGS library preparation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the global NGS library preparation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global NGS library preparation market.

The key players operating in the global NGS library preparation market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (U.S.), Tecan Group Ltd. (Switzerland), Merck KGaA (Germany), and Diagenode S.A. (Belgium) (Subsidiary of Hologic, Inc. (U.S.)).

Scope of the Report:

NGS Library Preparation Market, by Product

Reagents & Consumables
Library Preparation Kits
DNA Library Preparation Kits
RNA Library Preparation Kits
Other Reagents & Consumables
Instruments & Workstations

Note: Other reagents & consumables include various extraction kits, amplification kits, consumables, and laboratory reagents

NGS Library Preparation Market, by Application

Disease Diagnostics
Cancer Diagnostics
Reproductive Health Diagnostics
Infectious Disease Diagnostics
Other Disease Diagnostic Applications
Drug Discovery
Other Applications

Note: Other disease diagnostic applications include applications in cardiovascular diseases, detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and foodborne illnesses.

Note: Other applications include basic research (genomics, molecular biology, and other life sciences), agriculture & animal research, and forensics & food microbiology.

NGS Library Preparation Market, by Sequencing Type

Targeted Genome Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other Sequencing Types

Note: Other sequencing types include degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing

NGS Library Preparation Market, by End User

Hospitals & Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic Institutes & Research Centres
Others End Users

Note: Other end users include forensic laboratories & security agencies, the food industry, and the agriculture industry

NGS Library Preparation Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific (RoAPAC)
Latin America
Middle East & Africa

NGS Library Preparation Market

Report Metrics	Details
Years Considered	2021 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	227
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product, Market by Application, Market by Sequencing Type, Market by End User, and Market by Geography
Key Companies Mentioned	Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (U.S.), Tecan Group Ltd. (Switzerland), Merck KGaA (Germany), and Diagenode S.A. (Belgium) (Subsidiary of Hologic, Inc. (U.S.)).

FAQs About the Report

What is the scope of the NGS library preparation market study?

This market study covers the market sizes & forecasts of the NGS library preparation market based on product, application, sequencing type, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the NGS library preparation market at the regional and country levels.

What is the revenue generated from the sale of NGS library preparation products across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The NGS library preparation market is projected to reach $3.62 billion by 2030, at a CAGR of 14.8% during the forecast period of 2023–2030.

What are the various products of NGS library preparation, and which product segment holds the major share in the market?

Based on product, the NGS library preparation market is segmented into reagents & consumables and instruments & workstations. In 2023, the reagents & consumables segment is expected to account for the largest share of the NGS library preparation market due to the recurring demand for reagents & consumables and the high demand for NGS-based diagnostic testing.

What are the various applications of NGS library preparation, and which application segment holds the major share of the market?

Based on application, the NGS library preparation market is segmented into disease diagnostics, drug discovery, and other applications. In 2023, the disease diagnostics segment is expected to account for the largest share of the NGS library preparation market due to the high prevalence of various types of infectious diseases and cancers and the high-accuracy diagnosis provided by NGS-based tests.

What are the various sequencing types involved in NGS library preparation, and which sequencing type segment holds the major share of the market?

Based on sequencing type, the NGS library preparation market is segmented into targeted sequencing, whole genome sequencing, whole exome sequencing, and other sequencing types. In 2023, the targeted sequencing segment is expected to account for the largest share of the NGS library preparation market due to the faster speed and lower cost of targeted sequencing compared to other sequencing methods.

What are the various end users in the NGS library preparation market, and which end user segment holds the major share of the market?

Based on end user, the NGS library preparation market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2023, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the NGS library preparation market due to the high number of hospitalized patients, the increasing use of NGS in diagnostics, and the growing adoption of NGS-based diagnostics for disease diagnosis.

What are the key factors supporting the growth of this market? What are the major opportunities for the market players in the NGS library preparation market?

The growth of this market is driven by the declining costs of sequencing, the rising prevalence of genetic disorders, the increasing utilization of NGS in diagnostics, and the increasing R&D investments and healthcare expenditure.
Furthermore, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for the players operating in this market.
What are the factors hindering the growth of the NGS library preparation market?
The expensive nature of NGS library preparation solutions in developing countries is expected to hinder the growth of this market to a certain extent. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the limited expertise and sequencing capabilities of mid and small-sized laboratories are the major challenges to the growth of this market.

Who are the major players operating in the NGS library preparation market?

The key players operating in the NGS library preparation market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (U.S.), Tecan Group Ltd. (Switzerland), Merck KGaA (Germany), and Diagenode S.A. (Belgium) (Subsidiary of Hologic, Inc. (U.S.)).

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the NGS library preparation market?

The Asia-Pacific region is slated to witness the fastest growth rate during the forecast period and subsequently offer significant growth opportunities for the players operating in this market. The high market growth in Asia-Pacific is driven by governments’ increasing focus on sequencing projects, the rapid economic growth in Asia-Pacific countries, the increase in laboratory automation, and the rising research activities for developing personalized medicines.